GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » EV-to-FCF

JCR Pharmaceuticals Co (TSE:4552) EV-to-FCF : (As of May. 20, 2024)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, JCR Pharmaceuticals Co's Enterprise Value is 円84,375 Mil. JCR Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil. Therefore, JCR Pharmaceuticals Co's EV-to-FCF for today is .

The historical rank and industry rank for JCR Pharmaceuticals Co's EV-to-FCF or its related term are showing as below:

TSE:4552' s EV-to-FCF Range Over the Past 10 Years
Min: -13.84   Med: 41.7   Max: 42.74
Current: 8.87

During the past 13 years, the highest EV-to-FCF of JCR Pharmaceuticals Co was 42.74. The lowest was -13.84. And the median was 41.70.

TSE:4552's EV-to-FCF is ranked better than
83.27% of 520 companies
in the Drug Manufacturers industry
Industry Median: 25.045 vs TSE:4552: 8.87

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-20), JCR Pharmaceuticals Co's stock price is 円636.00. JCR Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円43.910. Therefore, JCR Pharmaceuticals Co's PE Ratio for today is 14.48.


JCR Pharmaceuticals Co EV-to-FCF Historical Data

The historical data trend for JCR Pharmaceuticals Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co EV-to-FCF Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,236.94 154.65 -125.90 -13.23 11.49

JCR Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.23 - - - -

Competitive Comparison of JCR Pharmaceuticals Co's EV-to-FCF

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's EV-to-FCF falls into.



JCR Pharmaceuticals Co EV-to-FCF Calculation

JCR Pharmaceuticals Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=84374.595/0
=

JCR Pharmaceuticals Co's current Enterprise Value is 円84,375 Mil.
JCR Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JCR Pharmaceuticals Co  (TSE:4552) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

JCR Pharmaceuticals Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=636.00/43.910
=14.48

JCR Pharmaceuticals Co's share price for today is 円636.00.
JCR Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円43.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


JCR Pharmaceuticals Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines